Cited by 23Kruppel-like factors researchTelomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Krüppel-Like Factor 6 Is Required for Oxidative and Oncogene-Induced Cellular Senescence

Open access
Sabatino, Maria Eugenia, Castellaro, Andrés, Racca, Ana C., Carbajosa González, Sofía, Pansa, Maria Florencia, Soria, Gastón, Bocco, Jose Luis·2019·Frontiers in Cell and Developmental Biology

Abstract

KLF6 is a transcription factor involved in the regulation of several cellular processes. Regarding its role in tumorigenesis, KLF6 is considered a tumor suppressor. Numerous reports demonstrate its frequent genomic loss or down-regulation, implying a functional inactivation in a broad range of human cancers. Previous work from our laboratory showed that the down-regulation of KLF6 expression in normal fibroblasts leads to cellular transformation, while its ectopic expression interferes with the oncogenic transformation triggered by activated Ras through a cell cycle arrest. We hypothesize that the growth suppressor activity of KLF6 may involve the induction of cellular senescence thereby helping to prevent the proliferation of cells at risk of neoplastic transformation. Here, we explored the association of KLF6 up-regulation in two different cellular senescence scenarios. We found that KLF6 silencing bypasses both oxidative and oncogene-induced senescence. In this context, KLF6 expression per se was capable to trigger cellular senescence in both normal and tumoral contexts. As such, the findings presented in this report provide insights into a potential mechanism by which KLF6 may play a suppressing role of uncontrolled or damaged cell proliferation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcell.2019.00297

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • KLF6 and ATF3 are implicated in p21 regulation and senescence establishment.

    “as well as KLF6 and ATF3, both implicated in p21 regulation and senescence establishment.61,62,63”
  • Genes upregulated in at least three senescent populations included NFKB1, KLF6, and ATF3.

    “These included the previously discussed TF NFKB1, known for SASP regulation, as well as KLF6 and ATF3, both implicated in p21 regulation and senescence establishment.61,62,63”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 68 · Cited by 23

Research works printed but not linked: 56

  1. Andreoli V. Gehrau R. C. Bocco J. L. (2010). Biology of kruppel-like factor 6 transcriptional regulator in cell life and death. IUBMB. Life 62 896– 905. 10.1002/iub.396 21154818 · DOI
  2. Banck M. S. Beaven S. W. Narla G. Walsh M. J. Friedman S. L. Beutler A. S. (2006). KLF6 degradation after apoptotic DNA damage. FEBS Lett. 580 6981– 6986. 10.1016/j.febslet.2006.10.077 17113081 · DOI
  3. Bartkova J. Rezaei N. Liontos M. Karakaidos P. Kletsas D. Issaeva N. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 633– 637. 10.1038/nature05268 17136093 · DOI · Paper page
  4. Benzeno S. Narla G. Allina J. Cheng G. Z. Reeves H. L. Banck M. S. (2004). Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res. 64 3885– 3891. 10.1158/0008-5472.can-03-2818 15172998 · DOI
  5. Bieker J. J. (2001). Kruppel-like factors: three fingers in many pies. J. Biol. Chem. 276 34355– 34358. 10.1074/jbc.r100043200 11443140 · DOI
  6. Botella L. M. Sanchez-Elsner T. Sanz-Rodriguez F. Kojima S. Shimada J. Guerrero-Esteo M. (2002). Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood 100 4001– 4010. 10.1182/blood.v100.12.4001 12433697 · DOI
  7. Botella L. M. Sanz-Rodriguez F. Komi Y. Fernandez L. A. Varela E. Garrido-Martin E. M. (2009). TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction. Biochem. J. 419 485– 495. 10.1042/BJ20081434 19076057 PMC2882110 · DOI
  8. Braig M. Lee S. Loddenkemper C. Rudolph C. Peters A. H. Schlegelberger B. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 660– 665. 10.1038/nature03841 16079837 · DOI · Paper page
  9. Bureau C. Hanoun N. Torrisani J. Vinel J. P. Buscail L. Cordelier P. (2009). Expression and function of kruppel like-factors (klf) in carcinogenesis. Curr. Genom. 10 353– 360. 10.2174/138920209788921010 20119532 PMC2729999 · DOI
  10. Campisi J. (2001). Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11 S27– S31. 11684439
  11. Campisi J. d’Adda di Fagagna F. (2007). Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell. Biol. 8 729– 740. 10.1038/nrm2233 17667954 · DOI · Paper page
  12. Childs B. G. Baker D. J. Kirkland J. L. Campisi J. Van Deursen J. M. (2014). Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 15 1139– 1153. 10.15252/embr.201439245 25312810 PMC4253488 · DOI · Paper page
  13. D’Astolfo D. S. Gehrau R. C. Bocco J. L. Koritschoner N. P. (2008). Silencing of the transcription factor KLF6 by siRNA leads to cell cycle arrest and sensitizes cells to apoptosis induced by DNA damage. Cell Death Differ. 15 613– 616. 10.1038/sj.cdd.4402299 18188167 · DOI
  14. Debacq-Chainiaux F. Erusalimsky J. D. Campisi J. Toussaint O. (2009). Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4 1798– 1806. 10.1038/nprot.2009.191 20010931 · DOI · Paper page
  15. Di Leonardo A. Linke S. P. Clarkin K. Wahl G. M. (1994). DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8 2540– 2551. 10.1101/gad.8.21.2540 7958916 · DOI · Paper page
  16. Di Micco R. Fumagalli M. Cicalese A. Piccinin S. Gasparini P. Luise C. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444 638– 642. 10.1038/nature05327 17136094 · DOI · Paper page
  17. DiFeo A. Martignetti J. A. Narla G. (2009). The role of KLF6 and its splice variants in cancer therapy. Drug Resist. Updat. 12 1– 7. 10.1016/j.drup.2008.11.001 19097929 · DOI
  18. Dimri G. P. Lee X. Basile G. Acosta M. Scott G. Roskelley C. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 9363– 9367. 10.1073/pnas.92.20.9363 7568133 PMC40985 · DOI · Paper page
  19. Dionyssiou M. G. Salma J. Bevzyuk M. Wales S. Zakharyan L. Mcdermott J. C. (2013). Kruppel-like factor 6 (KLF6) promotes cell proliferation in skeletal myoblasts in response to TGFbeta/Smad3 signaling. Skelet. Muscle 3: 7. 10.1186/2044-5040-3-7 23547561 PMC3669038 · DOI
  20. Frippiat C. Chen Q. M. Zdanov S. Magalhaes J. P. Remacle J. Toussaint O. (2001). Subcytotoxic H2O2 stress triggers a release of transforming growth factor-beta 1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J. Biol. Chem. 276 2531– 2537. 10.1074/jbc.m006809200 11060295 · DOI
  21. Gehrau R. C. D’astolfo D. S. Andreoli V. Bocco J. L. Koritschoner N. P. (2011). Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells. Mutat. Res. 707 15– 23. 10.1016/j.mrfmmm.2010.12.002 21147133 · DOI
  22. Hagos E. G. Ghaleb A. M. Dalton W. B. Bialkowska A. B. Yang V. W. (2009). Mouse embryonic fibroblasts null for the Kruppel-like factor 4 gene are genetically unstable. Oncogene 28 1197– 1205. 10.1038/onc.2008.465 19137014 PMC2667867 · DOI
  23. Halazonetis T. D. Gorgoulis V. G. Bartek J. (2008). An oncogene-induced DNA damage model for cancer development. Science 319 1352– 1355. 10.1126/science.1140735 18323444 · DOI · Paper page
  24. Holst C. R. Nuovo G. J. Esteller M. Chew K. Baylin S. B. Herman J. G. (2003). Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63 1596– 1601. 12670910
  25. Ito G. Uchiyama M. Kondo M. Mori S. Usami N. Maeda O. (2004). Kruppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res. 64 3838– 3843. 10.1158/0008-5472.can-04-0185 15172991 · DOI
  26. Keung E. Z. Akdemir K. C. Al Sannaa G. A. Garnett J. Lev D. Torres K. E. (2015). Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma. J. Clin. Invest. 125 2965– 2978. 10.1172/JCI77976 26193637 PMC4563740 · DOI
  27. Kiang J. G. Bowman P. D. Wu B. W. Hampton N. Kiang A. G. Zhao B. (2004). Geldanamycin treatment inhibits hemorrhage-induced increases in KLF6 and iNOS expression in unresuscitated mouse organs: role of inducible HSP70. J. Appl. Physiol. 97 564– 569. 10.1152/japplphysiol.00194.2004 15090481 · DOI
  28. Kimmelman A. C. Qiao R. F. Narla G. Banno A. Lau N. Bos P. D. (2004). Suppression of glioblastoma tumorigenicity by the kruppel-like transcription factor KLF6. Oncogene 23 5077– 5083. 10.1038/sj.onc.1207662 15064720 · DOI
  29. Kojima S. Hayashi S. Shimokado K. Suzuki Y. Shimada J. Crippa M. P. (2000). Transcriptional activation of urokinase by the kruppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells. Blood 95 1309– 1316. 10666204
  30. Kremer-Tal S. Reeves H. L. Narla G. Thung S. N. Schwartz M. Difeo A. (2004). Frequent inactivation of the tumor suppressor kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 40 1047– 1052. 10.1002/hep.20460 15486921 · DOI
  31. Lee B. Y. Han J. A. Im J. S. Morrone A. Johung K. Goodwin E. C. (2006). Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 5 187– 195. 16626397
  32. Masilamani A. P. Ferrarese R. Kling E. Thudi N. K. Kim H. Scholtens D. M. (2017). KLF6 depletion promotes NF-kappaB signaling in glioblastoma. Oncogene 36 3562– 3575. 10.1038/onc.2016.507 28166199 PMC5485221 · DOI
  33. Matsumoto N. Kubo A. Liu H. Akita K. Laub F. Ramirez F. (2006). Developmental regulation of yolk sac hematopoiesis by kruppel-like factor 6. Blood 107 1357– 1365. 10.1182/blood-2005-05-1916 16234353 PMC1895396 · DOI
  34. McConnell B. B. Yang V. W. (2010). Mammalian kruppel-like factors in health and diseases. Physiol. Rev. 90 1337– 1381. 10.1152/physrev.00058.2009 20959618 PMC2975554 · DOI
  35. Narla G. Difeo A. Yao S. Banno A. Hod E. Reeves H. L. (2005). Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res. 65 5761– 5768. 10.1158/0008-5472.can-05-0217 15994951 · DOI
  36. Narla G. Heath K. E. Reeves H. L. Li D. Giono L. E. Kimmelman A. C. (2001). KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294 2563– 2566. 10.1126/science.1066326 11752579 · DOI
  37. Narla G. Kremer-Tal S. Matsumoto N. Zhao X. Yao S. Kelley K. (2007). In vivo regulation of p21 by the kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma. Oncogene 26 4428– 4434. 10.1038/sj.onc.1210223 17297474 · DOI · Paper page
  38. Pospelova T. V. Demidenko Z. N. Bukreeva E. I. Pospelov V. A. Gudkov A. V. Blagosklonny M. V. (2009). Pseudo-DNA damage response in senescent cells. Cell Cycle 8 4112– 4118. 10.4161/cc.8.24.10215 19946210 PMC4970747 · DOI
  39. Racca A. C. Camolotto S. A. Ridano M. E. Bocco J. L. Genti-Raimondi S. Panzetta-Dutari G. M. (2011). Kruppel-like factor 6 expression changes during trophoblast syncytialization and transactivates sshCG and PSG placental genes. PLoS One 6: e22438. 10.1371/journal.pone.0022438 21799854 PMC3142166 · DOI
  40. Racca A. C. Ridano M. E. Bandeira C. L. Bevilacqua E. Avvad Portari E. Genti-Raimondi S. (2016). Low oxygen tension induces Kruppel-Like Factor 6 expression in trophoblast cells. Placenta 45 50– 57. 10.1016/j.placenta.2016.07.006 27577710 · DOI
  41. Racca A. C. Ridano M. E. Camolotto S. Genti-Raimondi S. Panzetta-Dutari G. M. (2015). A novel regulator of human villous trophoblast fusion: the kruppel-like factor 6. Mol. Hum. Reprod. 21 347– 358. 10.1093/molehr/gau113 25537765 · DOI
  42. Rodriguez R. Meuth M. (2006). Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress. Mol. Biol. Cell. 17 402– 412. 10.1091/mbc.e05-07-0594 16280359 PMC1345677 · DOI
  43. Roninson I. B. (2002). Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 179 1– 14. 10.1016/s0304-3835(01)00847-3 11880176 · DOI · Paper page
  44. Rubinstein M. Idelman G. Plymate S. R. Narla G. Friedman S. L. Werner H. (2004). Transcriptional activation of the insulin-like growth factor I receptor gene by the kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53. Endocrinology 145 3769– 3777. 10.1210/en.2004-0173 15131018 · DOI
  45. Sabatino M. E. Petiti J. P. Sosa Ldel V. Perez P. A. Gutierrez S. Leimgruber C. (2015). Evidence of cellular senescence during the development of estrogen-induced pituitary tumors. Endocr. Relat. Cancer 22 299– 317. 10.1530/ERC-14-0333 25792544 · DOI
  46. Sabatino M. E. Sosa Ldel V. Petiti J. P. Mukdsi J. H. Mascanfroni I. D. Pellizas C. G. (2013). Functional Toll-like receptor 4 expressed in lactotrophs mediates LPS-induced proliferation in experimental pituitary hyperplasia. Exp. Cell Res. 319 3020– 3034. 10.1016/j.yexcr.2013.08.012 23973924 · DOI
  47. Senturk S. Mumcuoglu M. Gursoy-Yuzugullu O. Cingoz B. Akcali K. C. Ozturk M. (2010). Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology 52 966– 974. 10.1002/hep.23769 20583212 · DOI
  48. Sirach E. Bureau C. Peron J. M. Pradayrol L. Vinel J. P. Buscail L. (2007). KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Cell Death Differ. 14 1202– 1210. 10.1038/sj.cdd.4402114 17347668 · DOI
  49. Slavin D. A. Koritschoner N. P. Prieto C. C. Lopez-Diaz F. J. Chatton B. Bocco J. L. (2004). A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function. Oncogene 23 8196– 8205. 10.1038/sj.onc.1208020 15378003 · DOI
  50. Stein G. H. Drullinger L. F. Soulard A. Dulic V. (1999). Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell Biol. 19 2109– 2117. 10.1128/mcb.19.3.2109 10022898 PMC84004 · DOI · Paper page
  51. Tahara E. Kadara H. Lacroix L. Lotan D. Lotan R. (2009). Activation of protein kinase C by phorbol 12-myristate 13-acetate suppresses the growth of lung cancer cells through KLF6 induction. Cancer Biol. Ther. 8 801– 807. 10.4161/cbt.8.9.8186 19333010 · DOI
  52. Tetreault M. P. Yang Y. Katz J. P. (2013). Kruppel-like factors in cancer. Nat. Rev. Cancer 13 701– 713. 24060862
  53. Trucco L. D. Andreoli V. Nunez N. G. Maccioni M. Bocco J. L. (2014). Kruppel-like factor 6 interferes with cellular transformation induced by the H-ras oncogene. FASEB J. 28 5262– 5276. 10.1096/fj.14-251884 25212220 · DOI
  54. Urtasun R. Cubero F. J. Nieto N. (2012). Oxidative stress modulates KLF6Full and its splice variants. Alcohol Clin. Exp. Res. 36 1851– 1862. 10.1111/j.1530-0277.2012.01798.x 22486562 PMC3396787 · DOI
  55. Volonte D. Zhang K. Lisanti M. P. Galbiati F. (2002). Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol. Biol. Cell 13 2502– 2517. 10.1091/mbc.01-11-0529 12134086 PMC117330 · DOI
  56. Warke V. G. Nambiar M. P. Krishnan S. Tenbrock K. Geller D. A. Koritschoner N. P. (2003). Transcriptional activation of the human inducible nitric-oxide synthase promoter by kruppel-like factor 6. J. Biol. Chem. 278 14812– 14819. 10.1074/jbc.m300787200 12590140 · DOI

Authors
Sabatino, M. E., Castellaro, A., Racca, A. C., Carbajosa González, S., Pansa, M. F., Soria, G., & Bocco, J. L.
Affiliations
Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
Venue
Frontiers in Cell and Developmental Biology
Published
2019-11-22
Volume
7
Pages
297-297
ISSN
2296-634X (ISSN-L)
OpenAlex
W2991591952
Cited by
23
References
68
Citations by year
2026: 5 · 2025: 6 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 2
FWCI
0.50
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
Funders
  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • Agencia Nacional de Promoción Científica y Tecnológica
  • Secretaria de Ciencia y Tecnología - Universidad Nacional de Córdoba
  • Instituto Nacional del Cáncer
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
KLF6, cellular senescence, oxidative stress, oncogene-induced senescence, tumor suppressor, transcription factors, cell cycle arrest, fibroblasts, carcinogenesis, growth inhibition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review